PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.\', \'Laboratory of Immune Regulation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.\', \'Reseach Center for Drug and Vaccine Development, National Institute of Infection Diseases, Tokyo, Japan.\', \'KOTAI Biotechnologies, Inc., Osaka, Japan.\', \'Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.\', \'Laboratory of Virus Control, Center for Infectious Diseases Education and Research, Osaka University, Osaka, Japan.\', \'Mahidol-Osaka Center for Infectious Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.\', \'Mahidol-Osaka Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.\', \'Tokyo Shinagawa Hospital, Tokyo, Japan.\', \'Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.\', \'Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kawasaki, Japan.\', \'Laboratory for Lymphocyte Differentiation, Research Center for Allergy and Immunology, RIKEN, Yokohama, Japan.\', \'Center for Infectious Diseases Education and Research, Osaka University, Osaka, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e2021100310.1084/jem.20211003
?:hasPublicationType
?:journal
  • The Journal of experimental medicine
is ?:pmid of
?:pmid
?:pmid
  • 34623376
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34623376>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34623376>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all